PDUFA IV meeting
Executive Summary
FDA will hold a public meeting to gather input for its PDUFA reauthorization proposal regarding what aspects of the user fee system should be retained or changed. The meeting will be held Nov. 14, 2005 at the Natcher Conference Center, National Institutes of Health, Bldg. 45, Center Dr., 9000 Rockville Pike, Bethesda, Md. The user fee program is set to expire in September 2007...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.